TRxADE HEALTH(MEDS) - 2019 Q4 - Annual Report

FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from: to_ 001-39199 (Commission File Number) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 TRXADE GROUP, INC. (Exact name of registrant as specified in its charter) Delaware 46-3673928 (State or ...